Geode Capital Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $239K | Buy |
7,476
+926
| +14% | +$25.7K | ﹤0.01% | 3813 |
|
|
2026
Q2 | $155K | Sell |
6,550
-5,529
| -46% | -$126K | ﹤0.01% | 3993 |
|
|
2026
Q1 | $130K | Buy |
12,079
+5,893
| +95% | +$58.7K | ﹤0.01% | 4065 |
|
|
2025
Q4 | $55K | Buy |
6,186
+878
| +17% | +$11K | ﹤0.01% | 4218 |
|
|
2025
Q3 | $85.5K | Buy |
5,308
+632
| +14% | +$12K | ﹤0.01% | 4169 |
|
|
2025
Q2 | $95.3K | Buy |
4,676
+161
| +4% | +$3.36K | ﹤0.01% | 4071 |
|
|
2025
Q1 | $78.1K | Sell |
4,515
-31
| -0.7% | -$646 | ﹤0.01% | 4099 |
|
|
2024
Q4 | $102K | Sell |
4,546
-298
| -6% | -$5.81K | ﹤0.01% | 4091 |
|
|
2024
Q3 | $87.5K | Sell |
4,844
-10
| -0.2% | -$206 | ﹤0.01% | 4144 |
|
|
2024
Q2 | $77.5K | Buy |
4,854
+271
| +6% | +$5.39K | ﹤0.01% | 4196 |
|
|
2024
Q1 | $103K | Buy |
4,583
+117
| +3% | +$2.62K | ﹤0.01% | 4153 |
|
|
2023
Q4 | $105K | Buy |
4,466
+73
| +2% | +$1.48K | ﹤0.01% | 4177 |
|
|
2023
Q3 | $105K | Buy |
4,393
+147
| +3% | +$3.71K | ﹤0.01% | 4235 |
|
|
2023
Q2 | $122K | Buy |
4,246
+16
| +0.4% | +$580 | ﹤0.01% | 4254 |
|
|
2023
Q1 | $257K | Buy |
4,230
+39
| +0.9% | +$3.44K | ﹤0.01% | 3922 |
|
|
2022
Q4 | $385K | Buy |
4,191
+21
| +0.5% | +$1.74K | ﹤0.01% | 3795 |
|
|
2022
Q3 | $502K | Buy |
4,170
+72
| +2% | +$8.66K | ﹤0.01% | 3725 |
|
|
2022
Q2 | $314K | Sell |
4,098
-69
| -2% | -$6.92K | ﹤0.01% | 4007 |
|
|
2022
Q1 | $647K | Buy |
4,167
+125
| +3% | +$21.1K | ﹤0.01% | 3816 |
|
|
2021
Q4 | $973K | Buy |
4,042
+537
| +15% | +$178K | ﹤0.01% | 3738 |
|
|
2021
Q3 | $1.51M | Buy |
3,505
+756
| +28% | +$346K | ﹤0.01% | 3485 |
|
|
2021
Q2 | $1.5M | Sell |
2,749
-729
| -21% | -$320K | ﹤0.01% | 3397 |
|
|
2021
Q1 | $1.36M | Buy |
3,478
+379
| +12% | +$199K | ﹤0.01% | 3430 |
|
|
2020
Q4 | $1.33M | Buy |
3,099
+578
| +23% | +$276K | ﹤0.01% | 3273 |
|
|
2020
Q3 | $2.15M | Buy |
2,521
+263
| +12% | +$211K | ﹤0.01% | 2843 |
|
|
2020
Q2 | $1.87M | Sell |
2,258
-49
| -2% | -$28.7K | ﹤0.01% | 2882 |
|
|
2020
Q1 | $855K | Buy |
2,307
+161
| +8% | +$80.4K | ﹤0.01% | 3077 |
|
|
2019
Q4 | $817K | Buy |
2,146
+390
| +22% | +$255K | ﹤0.01% | 3346 |
|
|
2019
Q3 | $2.98M | Buy |
1,756
+31
| +2% | +$46.9K | ﹤0.01% | 2695 |
|
|
2019
Q2 | $2.76M | Buy |
+1,725
| New | +$3.42M | ﹤0.01% | 2744 |
|
Other funds holding KRSA
Geode Capital Management's KRSA Position: Q3 2026 in Review
Geode Capital Management increased its Korsana Biosciences, Inc. Common Stock (KRSA) stake by 14% in Q3 2026, buying an estimated $25.7K and bringing the position to 7,476 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #3813.
Geode Capital Management first reported a position in KRSA in Q2 2019 and has held it in 30 quarters since. The position peaked at $2.98M in Q3 2019. 5 funds tracked by Wall St. Rank hold KRSA as of Q3 2026.
- Geode Capital Management held 7,476 shares of Korsana Biosciences, Inc. Common Stock worth $239K as of Q3 2026.
- Geode Capital Management bought 926 Korsana Biosciences, Inc. Common Stock shares in Q3 2026, an estimated $25.7K.
- Korsana Biosciences, Inc. Common Stock made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3813 holding.
- Geode Capital Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and has held it in 30 quarters since.
- Geode Capital Management's Korsana Biosciences, Inc. Common Stock position peaked at $2.98M in Q3 2019.
- 5 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.